Axsome Therapeutics
AXSM
AXSM
171 hedge funds and large institutions have $627M invested in Axsome Therapeutics in 2021 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 37 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
15% less call options, than puts
Call options by funds: $49M | Put options by funds: $57.3M
58% less capital invested
Capital invested by funds: $1.51B → $627M (-$880M)
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
171
Holding in Top 10
1
Calls
$49M
Puts
$57.3M
Top Buyers
| 1 | +$13.2M | |
| 2 | +$10.7M | |
| 3 | +$9.15M | |
| 4 |
Jane Street
New York
|
+$6.28M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.81M |
Top Sellers
| 1 | -$112M | |
| 2 | -$29.4M | |
| 3 | -$27.5M | |
| 4 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$24.3M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$24M |